Veralto has entered into a definitive agreement to acquire GlobalVision, subject to customary closing conditions. The purchase price is approximately 15x estimated adjusted EBITDA of $13m, which is comprised of 2026 estimated standalone adjusted EBITDA plus cost synergies expected to be achieved by the end of year two.
GlobalVision, headquartered in Montreal, leverages its core proprietary deterministic technology with AI-augmented functionality to help pharmaceutical and consumer packaged goods customers accelerate their speed to market and meet critical quality and packaging compliance regulations, verifying that packaging content remains accurate and compliant at every critical hand-off.
GlobalVision will be integrated into the company’s Esko business, building on their decade‑long partnership and embedding an AI‑augmented quality and compliance backbone directly into Esko’s end‑to‑end, source‑to‑shelf packaging platform.
“Consumer packaged goods and pharmaceutical companies are facing incredible demands to meet regulatory and brand consistency standards as they introduce new products to market quickly and accurately,” said Jennifer L. Honeycutt, President and Chief Executive Officer, Veralto. “Embedding GlobalVision’s core technology into Esko’s workflow solutions will help our customers get products to market faster and avoid costly errors by ensuring packaging is accurate and compliant.”
“We’ve spent decades building GlobalVision to ensure that the most critical packaging content in the world is accurate, compliant, and trusted,” said Brandon Malz, Chief Executive Officer, GlobalVision. “Joining Esko and Veralto is a natural next step — it allows us to embed that capability directly into the packaging lifecycle at global scale. Together, we see a unique opportunity to bring AI-augmented quality and compliance deeper into our customers’ workflows and fundamentally transform how products are brought to market.”
